The effect of miglitol on glucose, blood pressure, and heart rate variability in patients with type 2 diabetes.
- Conditions
- Heart failure or acute myocardial infarction with type 2 diabetes.
- Registration Number
- JPRN-UMIN000015385
- Lead Sponsor
- Jichi Medical University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Not provided
1. Patients with significant arrhythmia such as atrial fibrilation. 2. Patients with decompensated heart failure, fever, inflammation (CRP>1.0mg/dl) 3. Patients who are using insulin 4. Hepatic damage (AST, ALT >100 IU/L) 5. Patients with HBV, or HCV infection 6. Moderate renal dysfunction (serum creatinine >2.0mg/dl) 7. Patients with inflammatory bowel disease, colon ulcer, and bowel obstruction. 8. Severe chronic bowel diseases 9. Patients who have disease with increased bowel gas. 10. Patients with a history of gastric resection. 11. Lactose intolerance 12. Pregnant women or possible pregnancy. 13. Contraindication for miglitol 14. Dementia from whom we cannot obtain informed consent. 15. For whom the attending doctor considered he or she is not appropriate for the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method